Transition Metal Oxide‐Decorated MXenes as Drugless Nanoarchitectonics for Enriched Nanocatalytic Chemodynamic Treatment
Advanced Healthcare Materials · 2024-04 · 13 (10)
DOI: 10.1002/adhm.202303582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.01.2024. Verfasst von Hong-Ying Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Huaqiao University, Xiamen, 361021, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Fundamental Research Funds for Central Universities, Ministry of Science and Technology China.
Abstract (Originalsprache)
Despite their unique characteristics, 2D MXenes with sole photothermal conversion ability are required to explore their superfluous abilities in biomedicine. The small‐molecule‐based chemotherapeutics suffer from various shortcomings of time‐consuming and expensiveness concerning theoretical and performance (preclinical/clinical) checks. This study demonstrates the fabrication of Ti 3 C 2 MXene nanosheets (TC‐MX NSs) and subsequent decoration with transition metal oxides, that is, copper oxide (Cu 2 O/MX, CO‐MX NCs) as drugless nanoarchitectonics for synergistic photothermal (PTT)–chemodynamic therapeutic (CDT) efficacies. Initially, the monolayer/few‐layered TC‐MX NSs are prepared using the chemical etching‐assisted ultrasonic exfoliation method and then deposited with Cu 2 O nanoconstructs using the in situ reduction method. Further, the photothermal ablation under near‐infrared (NIR)‐II laser irradiation shows PTT effects of CO‐MX NCs. The deposited Cu 2 O on TC‐MX NSs facilitates the release of copper (Cu + ) ions in the acidic microenvironment intracellularly for Fenton‐like reaction‐assisted CDT effects and enriched PTT effects synergistically. Mechanistically, these deadly free radicals intracellularly imbalance the glutathione (GSH) levels and result in mitochondrial dysfunction, inducing apoptosis of 4T1 cells. Finally, the in vivo investigations in BALB/c mice confirm the substantial ablation of breast carcinoma. Together, these findings demonstrate the potential synergistic PTT–CDT effects of the designed CO‐MX NCs as drugless nanoarchitectonics against breast carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Huaqiao University, Xiamen, 361021, China.
- Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, 361021, China.
- Fujian Provincial Key Laboratory of Biochemical Technology, Huaqiao University, Xiamen, 361021, China.
ORCID-Profile: Ranjith Kumar Kankala
Förderung
- Natural Science Foundation of Fujian Province
- Fundamental Research Funds for Central Universities
- Ministry of Science and Technology China
- Program for Innovation Research Team in Science and Technology in Fujian Province University
- National Natural Science Foundation of China
- Science and Technology Projects in Fujian Province
Zitieren
APA
Xia, H. Y., Li, B. Y., Ye, Y. T., Wang, S. B., Chen, A. Z., & Kankala, R. K. (2024). Transition Metal Oxide‐Decorated MXenes as Drugless Nanoarchitectonics for Enriched Nanocatalytic Chemodynamic Treatment. Advanced Healthcare Materials, 13(10). https://doi.org/10.1002/adhm.202303582
Vancouver
Xia HY, Li BY, Ye YT, Wang SB, Chen AZ, Kankala RK. Transition Metal Oxide‐Decorated MXenes as Drugless Nanoarchitectonics for Enriched Nanocatalytic Chemodynamic Treatment. Advanced Healthcare Materials. 2024;13(10). doi:10.1002/adhm.202303582
BibTeX
@article{Xia2024,
author = {Xia, Hong-Ying and Li, Bo-Yi and Ye, Ying-Tong and Wang, Shi-Bin and Chen, Ai-Zheng and Kankala, Ranjith Kumar},
title = {Transition Metal Oxide‐Decorated MXenes as Drugless Nanoarchitectonics for Enriched Nanocatalytic Chemodynamic Treatment},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {10},
doi = {10.1002/adhm.202303582}
}
EUVIMED